Application Nr Approved Date Route Status External Links
NDA022173 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Zyprexa Relprevv Is Available Only Through A Restricted Distribution Program [See Warnings And Precautions ( 5.2 )] . Zyprexa Relprevv Must Not Be Dispensed Directly To A Patient. For A Patient To Receive Treatment, The Prescriber, Healthcare Facility, Patient, And Pharmacy Must All Be Enrolled In The Zyprexa Relprevv Patient Care Program. To Enroll, Call 1-877-772-9390. Zyprexa ® Relprevv™ Is A Long-Acting Atypical Antipsychotic For Intramuscular Injection Indicated For The Treatment Of Schizophrenia. ( 1.1 ) Efficacy Was Established In Two Clinical Trials In Patients With Schizophrenia: One 8-Week Trial In Adults And One Maintenance Trial In Adults. ( 14.1 ) 1.1 Schizophrenia Zyprexa Relprevv Is Indicated For The Treatment Of Schizophrenia. Efficacy Was Established In Two Clinical Trials In Patients With Schizophrenia: One 8-Week Trial In Adults And One Maintenance Trial In Adults [See Clinical Studies ( 14.1 )] .

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Olanzapine Pamoate

Comments